Clinical trial
Study of Pulmozyme to Treat Severe Asthma Episodes
NCT00169962 · Northwell Health, Other · Completed
Key facts
| NCT number | NCT00169962 |
|---|---|
| Title | Study of Pulmozyme to Treat Severe Asthma Episodes |
| Official title | Use of Aerosolized rhDNase (Pulmozyme®) in Emergency Department Adults With Refractory Acute Asthma: A Pilot Study |
| Lead sponsor | Northwell Health, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | rhDNAse (pulmozyme) |
| Enrollment | 51 |
| Start date | Jan 1, 2004 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Oct 12, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: